Matches in UGent Biblio for { <https://biblio.ugent.be/publication/3049315#aggregation> ?p ?o. }
Showing items 1 to 52 of
52
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B439153.
- aggregation creator B439154.
- aggregation creator B439155.
- aggregation creator B439156.
- aggregation creator B439157.
- aggregation creator B439158.
- aggregation creator B439159.
- aggregation creator B439160.
- aggregation creator B439161.
- aggregation creator B439162.
- aggregation creator B439163.
- aggregation creator B439164.
- aggregation creator B439165.
- aggregation creator B439166.
- aggregation creator B439167.
- aggregation creator B439168.
- aggregation creator B439169.
- aggregation creator B439170.
- aggregation creator B439171.
- aggregation creator B439172.
- aggregation creator person.
- aggregation date "2012".
- aggregation format "application/pdf".
- aggregation hasFormat 3049315.bibtex.
- aggregation hasFormat 3049315.csv.
- aggregation hasFormat 3049315.dc.
- aggregation hasFormat 3049315.didl.
- aggregation hasFormat 3049315.doc.
- aggregation hasFormat 3049315.json.
- aggregation hasFormat 3049315.mets.
- aggregation hasFormat 3049315.mods.
- aggregation hasFormat 3049315.rdf.
- aggregation hasFormat 3049315.ris.
- aggregation hasFormat 3049315.txt.
- aggregation hasFormat 3049315.xls.
- aggregation hasFormat 3049315.yaml.
- aggregation isPartOf urn:issn:0732-183X.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Early- and long-term outcome data of patients with Pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy".
- aggregation abstract "Purpose : Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous disease. The purpose of our study was to evaluate outcome and long-term survival after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) consolidated through an international registry study. Patients and Methods : A retrospective multi-institutional registry was established through collaborative efforts of participating units affiliated with the Peritoneal Surface Oncology Group International. Results : Two thousand two hundred ninety-eight patients from 16 specialized units underwent CRS for PMP. Treatment-related mortality was 2% and major operative complications occurred in 24% of patients. The median survival rate was 196 months (16.3 years) and the median progression-free survival rate was 98 months (8.2 years), with 10- and 15-year survival rates of 63% and 59%, respectively. Multivariate analysis identified prior chemotherapy treatment (P < .001), peritoneal mucinous carcinomatosis (PMCA) histopathologic subtype (P < .001), major postoperative complications (P = .008), high peritoneal cancer index (P = .013), debulking surgery (completeness of cytoreduction [CCR], 2 or 3; P < .001), and not using HIPEC (P = .030) as independent predictors for a poorer progression-free survival. Older age (P = .006), major postoperative complications (P < .001), debulking surgery (CCR 2 or 3; P < .001), prior chemotherapy treatment (P = .001), and PMCA histopathologic subtype (P < .001) were independent predictors of a poorer overall survival. Conclusion : The combined modality strategy for PMP may be performed safely with acceptable morbidity and mortality in a specialized unit setting with 63% of patients surviving beyond 10 years. Minimizing nondefinitive operative and systemic chemotherapy treatments before definitive cytoreduction may facilitate the feasibility and improve the outcome of this therapy to achieve long-term survival. Optimal cytoreduction achieves the best outcomes.".
- aggregation authorList BK766217.
- aggregation endPage "2456".
- aggregation issue "20".
- aggregation startPage "2449".
- aggregation volume "30".
- aggregation aggregates 3049364.
- aggregation isDescribedBy 3049315.
- aggregation similarTo JCO.2011.39.7166.
- aggregation similarTo LU-3049315.